Epidemiology of multiple system atrophy: A prevalence and pilot risk factor study in Aquitaine, France

Neuroepidemiology

Volumn 23, Issue 4, 2004, Pages 201-208

  Chrysostome, V ^a   Tison, F ^a,b   Yekhlef, F ^a   Sourgen, C ^a   Baldi, I ^a   Dartigues, J F ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b Hop du Haut Leveque   (France)

Author keywords

Multiple system atrophy; Pesticides; Prevalence; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PREVALENCE; RISK FACTOR; SHY DRAGER SYNDROME; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENVIRONMENT; EPIDEMIOLOGIC STUDIES; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; OCCUPATIONAL EXPOSURE; PESTICIDES; PREVALENCE; RISK FACTORS; SMOKING;

EID: 3242745883     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078506     Document Type: Article

References (67)

1. Graham JG, Oppenheimer DR: Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34.
2. Quinn NP: Multiple system atrophy - The nature of the beast. J Neurol Neurosurg Psychiatry 1989;52(suppl):78-89.
3. Papp MI, Kahn JE, Lantos PL: Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989;94:79-100.
4. Gilman S, Low PA, Quinn NP, Albanese A, Ben-Shlomo Y, Fowler CJ, et al: Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
5. Quinn NP: Multiple system atrophy; in Marsden CD, Fahn S (eds): Movement Disorders 3. London, Butterworth 1994, pp 256-275.
6. Papp MI, Lantos PL: The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994;117:235-243.
7. Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H: α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 1998;249:180-182.
8. Dickson DW, Lin WL, Liu WK, Yen SH: Multiple system atrophy: A sporadic synucleinopathy. Brain Pathol 1999;9:731-732.
9. Dickson DW, Liu WK, Hardy J, Farrer M, Mehta N, Uitti R, et al: Widespread alterations of α-synuclein in multiple system atrophy. Am J Pathol 1999;155:1241-1251.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
11. Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP: Clinical feature and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835-845.
12. Maraganore DM, Anderson DW, Bower JH, McDonnell SK, Rocca WA: Autopsy patterns for Parkinson's disease and related disorders in Olmsted County, Minnesota. Neurology 1999;53:1342-1344.
13. Schrag A, Ben Shlomo Y, Quinn NP: Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999;354:1771-1775.
14. Bower JH, Maraganore DM, McDonnell SK, Rocca WA: Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997;49:1284-1288.
15. Benecke R, Strümper P, Weiss H: Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain 1993;116:1451-1463.
16. Blin O, Desnuelle C, Rascol O, Borg M, Peyro Saint Paul H, Azulay JP, et al: Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci 1994;125:95-101.
17. Gu M, Gash MT, Cooper JM, Wenning GK, Daniel SE, Quinn NP, et al: Mitochondrial respiratory chain function in multiple system atrophy. Mov Disord 1997;12:418-422.
18. Bannister R, Mowbray J, Sidgwick A: Genetic control of progressive autonomic failure: evidence for an association with an HLA antigen. Lancet 1983;i:1017.
19. Nee LE, Brown RT, Polinsky RJ: HLA in autonomic failure. Arch Neurol 1989;46:758-759.
20. Jendroska K, Hoffmann O, Schelosky L, Lees AJ, Poewe W, Daniel SE: Absence of disease related prion in neurodegenerative disorders presenting with Parkinson's syndrome. J Neurol Neurosurg Psychiatry 1994;57:1249-1251.
21. Kato S, Meshitsuka S, Ohama E, Tanaka J, Llena JF, Hirano A: Increased iron content in the putamen of patients with striatonigral degeneration. Acta Neuropathol 1992;84:328-330.
22. Dexter DT, Jenner PJ, Schapira AHV, Marsden CD: Alterations in level of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann Neurol 1992;32(suppl):S94-S100.
23. Bandmann O, Sweeney MG, Daniel SE, Wenning GK, Quinn NP, Marsden CD, et al: Multiple system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration. Neurology 1997;49:1598-1604.
24. Iwahashi K, Miyatake R, Tsuneoka Y, Matsuo Y, Ichikawa Y, Hosokawa K, et al: A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:263-264.
25. Planté-Bordeneuve V, Bandmann O, Wenning GK, Quinn NP, Daniel SE, Harding AE: CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy. Mov Disord 1995;10:277-278.
26. Nicholl DJ, Bennett P, Hiller L, Bonifati V, Vanacore N, Fabbrini G, et al: A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. Neurology 1999;53:1415-1451.
27. Ozawa T, Takano H, Onodera O, Kobayashi H, Ikeuchi T, Koide R, et al: No mutation in the entire coding region of the α-synuclein gene in pathologically confirmed cases of multiple system atrophy. Neurosci Lett 1999;270:110-112.
28. Cairns NJ, Atkinson PF, Kovacs T, Lees AJ, Daniel SE, Lantos PL: Apolipoprotein E4 allele frequency in patients with multiple system atrophy. Neurosci Lett 1997;221:161-164.
29. Gascoigne RM, Hodgson DB, Kilindu TR, Oozeer NB: Relevance of PSP and MSA to clinical practice. Lancet 2000;355:754-755.
30. Kaufmann H: Multiple system atrophy. Curr Opin Neurol 1995;11:351-355.
31. Trenkwalder C, Schwarz J, Gebhard J, Ruland D, Trenkwalder P, Hense HW, et al: Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Arch Neurol 1995;52:1017-1022.
32. De Rijk MC, Breteler MMB, Graveland GA, Ott A, Grobbee DE, van der Meche FGA, et al: Prevalence of Parkinson's disease in the elderly: The Rotterdam study. Neurology 1995;45:2143-2146.
33. Schoenberg BS: Environmental risk factors for Parkinson's disease: The epidemiologic evidence. Can J Neurol Sci 1987;14(suppl 3):407-413.
34. Tanner CM, Chen B, Wang WZ, Peng ML, Liu ZL, Liang XL, et al: Environmental factors in the etiology of Parkinson's disease. Can J Neurol Sci 1987;14(suppl 3):419-423.
35. Semchuk KM, Love EJ, Lee RG: Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 1992;42:1328-1335.
36. Hubble JP, Cao T, Hassanein RES, Neuberger JS, Koller WC: Risk factors for Parkinson's disease. Neurology 1993;43:1693-1697.
37. Ritz B, Yu F: Parkinson's disease mortality and pesticide exposure in California 1984-1994. Int J Epidemiol 2000;29:323-329.
38. Hanna PA, Jankovic J, Kirkpatrick JB: Multiple system atrophy: the putative role of environmental toxins. Arch Neurol 1999;56:90-94.
39. Nee LE, Gomez MR, Dambriosa J, Bale S, Eldridge R, Polinsky RJ: Environmental-occupational risk factors and familial associations in multiple system atrophy: a preliminary investigation. Clin Auton Res 1991;1:9-13.
40. Tison F, Yekhlef F, Chrysostome V, Sourgen C: Prevalence of multiple system atrophy. Lancet 2000;355:495-496.
41. Gibb WRG, Lees AJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
42. Baldi I, Cantagrel A, Lebailly P, Tison F, Dubroca B, Chrysostome V: Association between Parkinson's disease and exposure to pesticides in Southwestern France. Neuroepidemiology 2003;22:305-310.
43. Yekhlef F, Ballan G, Macia F, Delmer O, Sourgen C, Tison F: Routine MRI for the diffrential diagnosis of Parkinson's disease, MSA, PSP, and CBD. J Neural Transm 2003;110:151-169.
44. Tison F, Arne P, Sourgen C, Chrysostome V, Yekhlef F: The value of external anal sphincter electromyography for the diagnosis of multiple system atrophy. Mov Disord 2000;15:1148-1157.
45. Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP: Clinicopathological study of 35 cases of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:160-166.
46. Wenning GK, Tison F, Ben shlomo Y, Daniel SE, Quinn NP: Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-147.
47. Wenning GK, Ben Shlomo Y, Hughes A, Daniel SE, Lees A, Quinn NP: What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease ? J Neurol Neurosurg Psychiatry 2000;68:434-440.
48. Hugues AJ, Ben-Shlomo Y, Daniel SE, Lees AJ: What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42:1142-1146.
49. Quinn NP, Marsden CD: The motor disorder of multiple system atrophy. J Neurol Neurosurg Psychiatry 1993;56:1239-1242.
50. Litvan I, Goetz CG, Jankovic J, Wenning GK, Booth V, Bartko JJ, et al: What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinico-pathologic study. Arch Neurol 1997;54:937-944.
51. Litvan I, Booth V, Wenning GK, Bartko JJ, McKee A, et al: Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy. J Neural Transm 1998;105:217-227.
52. Sakakibara R, Hattori T, Uchiyama T, Kita K, Ashina M, Suzuki A, Yamanishi T: Urinary dysfunction and orthostatic hypotension in multiple system atrophy: Which is the more common and earlier manifestation? J Neurol Neurosurg Psychiatry 2000;68:65-69.
53. Ben-Shlomo Y, Wenning GK, Tison F, Qunn NP: Survival of patients with pathologically proven multiple system atrophy: A meta-analysis. Neurology 1997;48:384-393.
54. Colosimo C, Vanacore N, Bonifati V, Fabbrini G, Rum A, De Michele G, et al: Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the Consensus Conference guidelines. Mov Disord 2000;15(suppl 3):S227.
55. Osaki Y, Ben-Shlomo Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, et al: Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 2002;59:1486-1491.
56. Wermuth L, Joensen P, Bünger N, Jeune B: High prevalence of Parkinson's disease in Faroe Islands. Neurology 1997;49:426-432.
57. Errea JM, Ara JR, Aibar C, de Pedro-Cuesta J: Prevalence of Parkinson's disease in lower Aragon, Spain. Mov Disord 1999;14:596-604.
58. Chio A, Magnani C, Schiffer D: Prevalence of Parkinson's disease in Northwestern Italy: Comparison of tracer methodology and clinical ascertainment of cases. Mov Disord 1998;13:400-405.
59. Colosimo C, Albanese A, Hughes AJ, de Bruin VMS, Lees AJ: Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995;52:294-298.
60. Gouider-Khouja N, Vidailhet M, Bonnet AM, Pichon J, Agid Y: 'Pure' striatonigral degeneration and Parkinson's disease: A comparative clinical study. Mov Disord 1995;10:288-294.
61. Klockgether T, Lüdtke R, Kramer B, Abele M, Bürk K, Schüls L, et al: The natural history of degenerative ataxia: A retrospective study in 466 patients. Brain 1998;121:589-600.
62. Lantos PL: The definition of multiple system atrophy: A review of recent developments. J Neuropathol Exp Neurol 1998;57:1099-1111.
63. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT: Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000;3:1301-1306.
64. Betarbet R, Sherer TB, Greenamyre JT: Animal models of Parkinson's disease. Bioessays 2002;24:308-318.
65. Vanacore N, Bonifati V, Fabbrini G, Colosimo C, Marconi R, Nicholl D, et al: Smoking habits in multiple system atrophy and progressive supranuclear palsy. Neurology 2000;54:114-119.
66. Wenning GK, Scherfler C, Granata R, Bösch S, Verny M, Chaudhuri KR, et al: Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: A clinicopathological study. J Neurol Neurosurg Psychiatry 1999;67:620-623.
67. Helmer C, Letenneur L, Rouch I, Richard-Harston S, Barberger-Gateau P, Fabrigoule C, et al: Occupation during life and risk of dementia in French elderly community residents. J Neurol Neurosurg Psychiatry 2001;71:289-290.